We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AKZA market cap is 9.92B. The company's latest EPS is EUR 3.1733 and P/E is 18.30.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 8.53B | 9.59B | 10.85B | 10.67B | 10.71B |
| Operating Income | 988M | 1.14B | 726M | 1.06B | 940M |
| Net Income | 630M | 829M | 352M | 442M | 542M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 13.18B | 13.88B | 14.74B | 14.56B | 14.25B |
| Total Liabilities | 7.23B | 8.24B | 10.19B | 10.01B | 9.43B |
| Total Equity | 5.95B | 5.64B | 4.55B | 4.55B | 4.82B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 1.22B | 605M | 263M | 1.13B | 673M |
| Investing | -427M | -134M | -1.1B | -144M | -132M |
| Financing | -353M | -974M | 1.14B | -827M | -684M |
| Market Cap | 9.92B |
| Price to Earnings Ratio | 18.30 |
| Price to Sales Ratio | 0.93 |
| Price to Cash Ratio | 7.62 |
| Price to Book Ratio | 2.06 |
| Dividend Yield | - |
| Shares Outstanding | 170.8M |
| Average Volume (1 week) | 481.12k |
| Average Volume (1 Month) | 633.83k |
| 52 Week Change | -14.62% |
| 52 Week High | 70.40 |
| 52 Week Low | 52.92 |
| Spread (Intraday) | 0.8 (1.37%) |
| Company Name | Akzo Nobel NV |
| Address |
christian neefestraat 2 amsterdam, north holland 1070 AS |
| Website | https://www.akzonobel.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
